References and Notes
1a
Lednicer D.
Mitscher LA. In Organic Chemistry of Drug Synthesis
Vol. 1:
Wiley Interscience;
New York:
1977.
p.226
1b
Bure F.
Kulhanek J.
Tetrahedron: Asymmetry
2005,
16:
1347
1c
Loksha YM.
El-Barbary AA.
El-Badawi MA.
Nielsen C.
Pedersen EB.
Bioorg. Med. Chem.
2005,
13:
4209
1d
Kumar R.
Lown JW.
Eur. J. Med. Chem.
2005,
40:
641
2a
Benner SA.
Heeb NV.
Tetrahedron Lett.
1994,
35:
3045
2b
Somayaji V.
Skorey KI.
Brown RS.
Ball RG.
J. Org. Chem.
1986,
51:
4866
3
Knapp S.
Albaneze J.
Schugar HJ.
J. Org. Chem.
1983,
58:
997
4a
Laufer S.
Wagner G.
Kotschenreuther D.
Angew. Chem. Int. Ed.
2002,
41:
2290
4b
Zhang C.
Sarshar S.
Moran EJ.
Krane S.
Rodarte JC.
Benbatoul KD.
Dixon R.
Mjalli AMM.
Bioorg. Med. Chem.
2000,
10:
2603
5 For recent reviews, see ‘Histamine H3 Receptor’: Menge WMPB.
Timmerman H.
Pharmacochem. Lib.
1998,
30:
145
6a
Sezen B.
Sames D.
J. Am. Chem. Soc.
2003,
125:
5274
6b
Tan KL.
Bergman RG.
Ellman JA.
J. Am. Chem. Soc.
2002,
124:
13964
6c
Sisko J.
Kassick AJ.
Mellinger M.
Filan JJ.
Allen A.
Olsen MA.
J. Org. Chem.
2000,
65:
1516
6d
Groarke M.
McKervey MA.
Nieuwenhuyzen M.
Tetrahedron Lett.
2000,
41:
1275
7
Guillemet M.
Robert A.
Baudy-Floc’h M.
Tetrahedron Lett.
1995,
36:
547 ; and references cited therein
8a
Little TL.
Webber SE.
J. Org. Chem.
1994,
59:
7299
8b
Teuber HJ.
Emmerich G.
Tetrahedron Lett.
1971,
18:
1459
8c
Sorrell TN.
Allen WE.
J. Org. Chem.
1994,
59:
1589
8d
Eissenstat MA.
Weaver JD.
J. Org. Chem.
1993,
58:
3387
9
Jayakumar S.
Mahajan MP.
Tetrahedron
2002,
58:
2899
10a
Jayakumar S.
Ishar MPS.
Mahajan MP.
Tetrahedron
2002,
58:
379
10b
Kumar V.
Mohan C.
Gupta M.
Mahajan MP.
Tetrahedron
2004,
61:
3533
10c
Mohan C.
Kumar V.
Mahajan MP.
Tetrahedron Lett.
2004,
45:
6075
10d
Marwaha A.
Singh P.
Mahajan MP.
Velumurugan D.
Tetrahedron Lett.
2004,
45:
8945
11
Nishi M.
Tanimoto S.
Okano M.
Oda R.
Yuki Gosei Kagaku Kyokai Shi
1969,
27:
754 ; Chem. Abstr. 1969, 71, 101438v
12 2,3-Diphenyl-3H-imidazol-4-ol (2a): mp 159-160 °C. Anal. Calcd for C15H12N2O (%): C, 76.25; H, 5.12; N, 11.86. Found C, 76.12; H, 5.03; N, 12.08. 1H NMR (300 MHz): δ = 7.28 (m, 1 H, ArH), 7.45-7.90 (m, 8 H, ArH), 7.96-8.00 (m, 3 H, 2 ArH + OH exchangeable with D2O). 13C NMR (75.4 MHz): δ = 119.8, 120.1, 124.5, 127.0, 128.8, 129.0, 129.3, 131.8, 134.5, 143.2, 145.8. MS: m/z = 236 [M+].
3-Phenyl-2-piperidin-1-yl-3H-imidazol-4-ol (2b): mp 143-144 °C. Anal. Calcd for C14H17N3O: C, 69.11; H, 7.04; N, 17.27. Found: C, 69.25; H, 6.96; N, 17.21. 1H NMR (300 MHz): δ = 1.65-1.69 (m, 6 H, -CH2CH2CH2-), 3.54-3.58 (m, 4 H, -CH2NCH2-), 7.05-7.14 (m, 4 H, ArH), 7.22-7.27 (m, 2 H, ArH), 10.72 (s, 1 H, OH exchangeable with D2O). 13C NMR (75.4 MHz): δ = 25.2 (-CH2), 26.0 (-CH2CH2-), 44.4 (-CH2NCH2-), 118.0, 126.5, 128.2, 129.1, 134.2, 142.2, 146.2. MS: m/z = 243.
(1,2-Diphenyl-1H-imidazol-4-yl)dimethylamine (10a): mp 116-118 °C. Anal. Calcd. for C17H17N3: C, 77.54; H, 6.51; N, 15.96. Found: C, 77.42; H, 6.38; N, 16.20. 1H NMR (300 MHz): δ = 3.1 [s, 6 H, -N(CH3)2], 7.18-7.48 (m, 11 H, ArH). 13C (75.4 MHz): δ = 44.0 [-N(CH3)2], 121.2, 122.8, 123.0, 124.8, 126.2, 128.1, 128.7, 131.0, 132.7, 136.2, 148.3. MS: m/z 263 [M+].